Biotech company developing therapies targeting gut-brain axis interactions to treat metabolic and neurological diseases.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Kallyope is a biotechnology company focused on harnessing the gut-brain axis to develop innovative therapies for various health conditions. Kallyope aims to unlock the complex interactions between metabolic, neurological, and gastrointestinal systems to create effective treatments for diseases such as obesity, diabetes, and neurological disorders.
Kallyope Funding
Sign up to gain insights into Kallyope funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series D | Feb 15, 2022 | 236M | ||
| Series C | Mar 18, 2020 | 112M | ||
| Series B | Dec 05, 2018 | 21M | ||
| Series B | Feb 22, 2018 | 66M | ||
| Series A | Oct 27, 2016 | 16M | ||
| Series A | Sep 30, 2015 | 12M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Kallyope Management Team
Investors
Alexandria Venture Investments
Column Group
Tao Capital Partners
Two Sigma
DNS Capital
Hartford HealthCare Endowment
Mubadala Investment Company
Casdin Capital
Polaris Partners
Euclidean Capital
Greenspring Associates
Parkwood
StepStone Group
Illumina
Lux Capital
Kallyope Valuations & Financials
View real-time NPM data on Kallyope stock including most recent valuation and historical share price information. Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.
Similar Companies
like Kallyope
Tonal
Health Care
Delivers AI-powered strength training with digital weights and personalized coaching.
Curology
Health Care
Offers personalized prescription skin care medications delivered directly to you.
Devoted
Health Care
Provides Medicare Advantage plans to improve older Americans' well-being with comprehensive and family-oriented care.
Cerebral
Health Care
Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.
Virta Health
Health Care
Online specialty medical clinic focused on reversing type 2 diabetes.
Element Biosciences
Health Care
Genetic analysis tools for the research and diagnostic markets.
Mammoth Biosciences
Health Care
Developed a CRISPR-based platform for disease to enable the detection of any type of nucleic acid.
FAQ
We have answers
Kallyope stock does not trade on public stock exchanges. Kallyope stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Kallyope stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Kallyope Stock does not trade on public stock exchanges. In order to sell Kallyope shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Kallyope does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Kallyope share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Kallyope stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Kallyope stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Kallyope stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Kallyope is a private company and has not had an IPO. There is currently no Kallyope IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Kallyope IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
